Effects of the COVID-19 Public Health Emergency on Formal Meetings and User Fee Applications for Medical Devices — Questions and Answers (Revised)

On 22 December 2020 the FDA published the updated Q&A guidance for industry and FDA staff.

FDA is issuing this guidance to provide answers to frequently asked questions about regulatory and policy issues related to device development for the duration of the COVID-19 public health emergency.

Read more online 
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /